Small Stocks, Big Money cover art

All Episodes

Small Stocks, Big Money — 151 episodes

#
Title
1

RedChip Highlights Virax Biolabs Group (NASDAQ: VRAX) & TransCode Therapeutics (NASDAQ: RNAZ)

2

RedChip Highlights Nord Precious Metals Mining Inc.(OTCQB: NPMMF) &OBOOK Holdings Inc.(NASDAQ: OWLS)

3

RedChip Highlights Venu Holding Corporation (NYSE American: VENU) & Proactive Sustainable Bonds

4

RedChip Highlights Bimergen Energy(NYSE American: BESS) & Alliance Entertainment (NASDAQ: AENT)

5

Alliance Entertainment (Nasdaq: AENT): Building the Authentication Layer for Vinyl Collectors

6

CEO Frank Basa on Nord Precious Metals' (OTCQB: NPMMF) 29 Veins Inside of One Historic Silver Camp

7

Alliance Entertainment (Nasdaq: AENT): $1B Revenue, 33% Movie Growth & the Collectibles Shift

8

CEO Paul Mann on ASP Isotopes (Nasdaq: ASPI): 4 Facilities, $38B Market & Western Supply Security

9

Co-CEO Bob Brilon on Bimergen Energy's (NYSE: BESS) 23-Project Energy Arbitrage Pipeline

10

CEO Lavell Malloy on Brag House's (Nasdaq: TBH) Blockchain Sports Platform & Athlete Tokenization

11

CEO James Foster on Virax Biolabs' (VRAX) Long COVID Diagnostic & US Market Entry

12

Jeremy Schwartz CIO of WisdomTree ($WT): $165B AUM, Mega Trends & Why WT Is a Secular Growth Stock

13

First Phosphate (FRSPF) CEO on Agnico's $94M Bet Leaves Only 2 Independents Standing

14

Anixa Biosciences (ANIX): CEO on Breast Cancer Vaccine, Phase 2 Catalyst & Ovarian Cancer CAR-T Data

15

CEO Brandon Robinson on Horizon Aircraft’s (HOVR) Commercial eVTOL Advantages

16

First Phosphate (FRSPF) CEO on $16.7M Non-Dilutive Funding, LFP Batteries, and Why FRSPF Stands Out

17

RedChip Highlights Enlivex Therapeutics Ltd. (NASDAQ: ENLV) & Off The Hook Inc. (NYSE American: OTH)

18

SCAP Portfolio Manager Jay Hatfield’s Market Playbook: Fed Cuts, Core PCE, and Small Caps

19

Enlivex (Nasdaq: ENLV) - FY25 Financial Results Webcast Replay

20

Enlivex (ENLV) CEO: Two Pillars of Growth, Allocetra Knee OA Catalyst + RAIN Treasury Optionality

21

Off The Hook (NYSE American: OTH) CEO Interview: $145M Revenue Path, AI Boat Platform, Apex Upside

22

Comprehensive Healthcare Systems (CMHSF | CHS): CEO Interview on Healthcare SaaS and Pipeline Growth

23

The Metals Company (TMC) CFO Craig Shesky: The NOAA Path, $23.6B NPV, and US Supply Security

24

BioVie (Nasdaq: BIVI) CEO Cuong Do on Near Term Catalysts in Parkinson’s, Long COVID, and Ascites

25

First Phosphate CEO John Passalacqua: Building a North American LFP Battery Supply Chain (FRSPF)

26

Nexalin Technology (NXL) CEO Mark White: FDA Trials, At-Home Neurostimulation, and 2026 Milestones

27

OBOOK Holdings (OWLS) CEO Darren Wang on Regulated Stablecoin Payments, OwlPay Growth and 2026 Goals

28

NioCorp (NB) CEO Mark Smith on 2025 Milestones, Elk Creek Portal Buildout, and U.S. EXIM Financing

29

ASP Isotopes (Nasdaq: ASPI) Investor Webinar - January 14, 2026

30

Avalon Advanced Materials CEO Interview | $4B Lithium Opportunity + Rare Earth Supply Chain Upside

31

Alliance Entertainment (NASDAQ: AENT) Chairman on Earnings Growth and Exclusive IP Strategy

32

Processa Pharmaceuticals (PCSA) Interview: Phase 2 Breast Cancer Data, Pipeline Strategy & FDA Path

33

New Era (Nasdaq: NUAI) CEO Discusses Power, AI Data Centers, and the Next Phase of Growth

34

NioCorp CEO Mark Smith on U.S. Critical Minerals, Scandium Demand, and Project Financing Progress

35

Nova Minerals CEO: $43.4M U.S. Funding Secured, Antimony Production by 2026 and 5.2Moz Gold Resource

36

BullFrog AI CEO Vin Singh: Using AI to Transform Drug Discovery and Cut Development Costs

37

Jackpot Digital CEO Jake Kalpakian on Disrupting the Casino Industry with Dealerless Poker Tech

38

Connect Biopharma CEO Barry Quart: Targeting a $5B+ Market with a Next-Gen Asthma & COPD Therapy

39

FatPipe Networks: CEO Dr. Ragula Bhaskar on Scaling Profitable Growth in SD-WAN and Cybersecurity

40

60 Degrees Pharmaceuticals: CEO Geoff Dow on Breakthrough Babesiosis Therapy & FDA Path Ahead

41

Inside Bimergen Energy: $250M Equity Backing & 2GW BESS Pipeline with CFO Bob Brilon

42

Inside Nexalin: Drug-Free Neuro Tech, Clinical Milestones, and What’s Next!

43

Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development

44

Foremost Clean Energy CEO on Nuclear's Resurgence & 330K Acre Uranium Portfolio

45

PhoenixEV CEO John Walsh Interview: 2025 Goals, $200M Backlog and Transit Growth

46

Inside 60 Degrees Pharmaceuticals: CEO Geoffrey Dow on Revenue Growth & Pipeline Potential

47

Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe

48

Investor Insights: Calidi CEO Eric Poma Discusses Breakthroughs in Oncolytic Virotherapy

49

Precision Oncology at Scale: Lantern Pharma’s Strategic Vision with CEO Panna Sharma

50

Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook

51

Inside Processa Pharma: CEO George Ng on Disrupting Oncology Drug Development

52

Greenwich LifeSciences' CEO on Advancing HER2+ Immunotherapy | Phase III Insights & Strategy

53

How Fathom Holdings Is Disrupting Real Estate with Tech & Flat-Fee Innovation | CEO Marco Fregenal

54

ASP Isotopes CEO Paul Mann on Transforming Global Isotope Supply for Medicine, Clean Energy, & More!

55

Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive

56

Inside 60 Degrees Pharma: CEO Geoffrey Dow on Fighting Infectious Diseases & Driving Growth

57

Uranium & Lithium Boom: Foremost Clean Energy CEO on the Future of North America's Supply

58

FatPipe (Nasdaq: FATN) CEO Talks Profitability, Patented Tech & Global Growth Strategy

59

BioVie CEO Cuong Do on Alzheimer’s Breakthroughs, Liver Disease Pipeline & What’s Ahead

60

Liberty Star Minerals: Leadership Breaks Down High-Grade Gold & Copper Potential in Arizona

61

Inside Atossa Therapeutics (Nasdaq: ATOS): CEO Dr. Steven Quay on Advancing Breast Cancer Treatment

62

Inside ConnectM: How AI Is Powering the $2 Trillion Electrification Boom

63

bioAffinity (Nasdaq: BIAF) CEO Maria Zannes Talks CyPath® Lung, Growth & AI Innovation

64

Interview with Connect Biopharma CEO Barry Quart | Transforming Acute Asthma & COPD Care

65

BullFrog AI CEO Vin Singh on Revolutionizing Drug Development with AI-Powered Insights

66

LiveOne (Nasdaq: LVO) CEO Robert Ellin on Disrupting Music, Media & Monetization

67

Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential

68

Inside Knightscope (Nasdaq: KSCP): CEO William Santana Li on AI, Robotics & Crime Prevention

69

Jupiter Neurosciences CEO Christer Rosén on Advancing Neuroinflammation Treatments & Beyond

70

Alliance Entertainment: Inside The Billion-Dollar Giant Powering Media Distribution Globally

71

Inside Calidi Biotherapeutics: CFO Andrew Jackson Breaks Down the Future of Oncolytic Virotherapy

72

60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoffrey Dow on Expanding Malaria Prevention & Beyond

73

Elevating Fan-Owned Live Entertainment: VENU Founder & CEO J.W. Roth Shares His Disruptive Approach

74

ASP Isotopes CEO Paul Mann on Breakthrough Isotope Tech, Quantum Computing & 2025 Growth Plans

75

Inside Enlivex: Oren Hershkovitz on Tackling Sepsis, Osteoarthritis, and Beyond with Allocetra™

76

Inside Gorilla Technology: CEO Jay Chandan & Interim CFO Bruce Bower on Smart Cities & Big Data

77

Inside OKYO Pharma’s (NASDAQ: OKYO) Phase 2 Trials with CEO Dr. Gary Jacob

78

Inside VSee Health’s Telehealth Revolution: Exclusive Interview with Co-CEO Dr. Imo Aisiku

79

Inside Can-Fite BioPharma’s (NASDAQ: CANF) Clinical Pipeline with CEO Motti Farbstein

80

How MUSQ ETF is Reshaping Music Investments: CEO David Shulhof Explains

81

The Future of Oncology: Calidi’s Stem Cell-Based Platforms for Fighting Cancer

82

How Alliance Entertainment (Nasdaq AENT) is Optimizing Operations for Continued Margin Improvement

83

The Gold Rush of 2024: Christopher Gerteisen’s Vision for Nova Minerals and Beyond

84

Interview with Founder of MUSQ Global Music Industry ETF

85

CEO Interview: ASP Isotopes is Commercializing New Isotope Enrichment Technology

86

CEO Interview: Discover How OKYO Pharma is Targeting the Multi-Billion-Dollar Dry Eye Disease Market

87

Learn Why Soligenix has Received $60M+ in Non-Dilutive Funding From the US Government: CEO Interview

88

Pioneering New Osteosarcoma and Breast Cancer Treatments: Exclusive Interview with OS Therapies' CEO

89

CEO INTERVIEW: American Resources Corporation's Unique Ability to Refine Critical Elements

90

GreenPower Leverages Government Mandates and Funding to Boost Zero-Emission School Bus Line Growth

91

Discover Nexalin's Neurostimulation Device Targeting Mental Health Disorders

92

Biotricity CEO, Waqaas Al-Siddiq, on New Heart Health Innovations & the Future of Cardiac Care

93

Hope for Lung Cancer Patients: Cypath Lung Test's Impact

94

Alta Global Group: Converting MMA fans into Participants. An Interview with CEO Nick Langton

95

Exploring Can-Fite BioPharma's Groundbreaking Drugs: Piclidenoson and Namodenoson

96

Unlocking Hope: The BioVie Journey in Neurodegeneration and Liver Disease

97

AI Solutions in the Online CBD Industry: A 1606 Corp. Perspective

98

Spectaire Holdings (Nasdaq: SPEC) Launches AireCore System for Emissions Management!

99

Genetic Technologies: Innovating Healthcare with Genomics-based Cancer Predictions

100

Unlocking Growth: Exploring LOBO EV's Path to Market Leadership in E-Bikes and EVs

101

Enlivex's (NASDAQ:ENLV) Allocetra™: Breakthrough Macrophage Reprogramming Therapy

102

Biotricity (NASDAQ: BTCY) Transforming Cardiac Care: Innovative Remote Monitoring Solutions

103

Unlocking Growth: Lytus Technologies - Your Next Nasdaq Investment Opportunity in Digital & Healthcare Innovation!

104

Biotricity (NASDAQ: BTCY) Revolutionizing Cardiac Care: Meet biotricity - Leading Remote Patient Monitoring Technology

105

Xcel Brands (NASDAQ:XELB): Leading the Social Commerce Revolution

106

1606 Corp. (OTC: CBDW): Revolutionizing CBD Customer Service with AI Innovation

107

Mobilicom (NASDAQ: MOB) Israel Ministry of Defense Purchases Mobilicom's Game-Changing Technology!

108

Meet Shalabh Gupta, CEO of Unicycive Therapeutics (NASDAQ: UNCY)

109

The INNO (NASDAQ: INHD) Edge: Transforming Construction with Cold-Formed Steel Technology

110

INNO Holdings Inc. (NASDAQ: INHD) - Redefining Construction with Steel Tech

111

Genetic Technologies Limited (NASDAQ: GENE): Pioneering Genomics for Health and Wellness

112

bioAffinity Technologies: Exploring the Future of Cancer Care

113

Meet Maria Zannes: CEO of BioAffinity Technologies (NASDAQ: BIAF)

114

Innovation in Flight: Mobilicom's End-to-End Solutions for Drone Cybersecurity

115

How Royalty Management Transforms Undervalued Assets

116

Meet Kirk Taylor: CFO of Royalty Management Holding Corporation (NASDAQ: RMCO)

117

Meet Paul Mann: CEO & Chairman of ASP Isotopes

118

Meet Denton Peng: CEO & Chairman of SPI

119

Meet Simon Morriss: CEO of Genetic Technologies (NASDAQ: GENE)

120

Meet Jonathan Guarino: CFO of Soligenix (NASDAQ: SNGX)

121

Meet Dr. Chris Schaber: CEO & President of Soligenix (NASDAQ: SNGX)

122

Meet Vu Truong, Founder and CEO of Aridis Pharmaceuticals (OTC: ARDS)

123

Everything Blockchain: Blending Database Security & Blockchain Technologies

124

Sharps Technology: Targeting Niche, Multi-Billion-Dollar Markets

125

Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium

126

Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

127

Graphex Group: Top-10 Global Producer of Graphite Anodes

128

Meet Shahar Hania, CEO of Rail Vision (NASDAQ:RVSN)

129

Splash Beverage: Ground-Floor Opportunity with High-Growth Beverage Brands

130

Soligenix: A Late-Stage Biopharma Pioneer Tackling Rare Diseases with Unmet Needs

131

ASP Isotopes: Advanced Materials Company Targeting Isotope Production

132

American Resources Corporation (NASDAQ: AREC): Focusing On Critical and Rare Earth Minerals for the Electrification Market

133

Meet Curt Marvis, The Man Behind QYOU Media. (OTCQB: QYOUF)

134

Aridis Pharma Founder & CEO Discusses Upcoming Milestones for its Late-Stage Pipeline

135

Interview with Sixty Degrees Pharma (Nasdaq: SXTP) CEO Geoff Dow

136

BioVie (NASDAQ: BIVI): Poised for Significant Catalysts in 2023

137

Meet Vin Singh, Founder & CEO of Bullfrog AI (NASDAQ:BFRG)

138

The Mark Jensen Story – From Wall Street Banker to Indiana Battery Recycler - American Resources Corporation (NASDAQ:AREC)

139

Rail Vision (NASDAQ: RVSN): Potentially Preventing Catastrophe’s Before They Occur

140

American Resources Corporation (NASDAQ: AREC): How this Company Turns Trash to Treasure

141

SPI Energy Group (NASDAQ: SPI): Unlocking Shareholder Value Under the Sun

142

Biovie (NASDAQ: BIVI): Innovating Potential Alzheimer’s and Parkinson’s Treatment

143

How Zomedica (NYSE American: ZOM) Is Changing the Veterinary Industry with Its Cutting-Edge Diagnostics and Therapeutics

144

End of the Exponential Equity Growth Era? Where to Invest Next

145

Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium

146

Reviva Pharma (NASDAQ: RVPH) Charting Success: Reviva Pharma's Journey from phase 3 to Potential NDA filing

147

Unlocking Precision Medicine: BullFrog AI's (Nasdaq: BFRG) Trailblazing Use of AI to Predict Therapeutic Success and Transform Drug Development

148

QYOU Media (OTCQB: QYOUF) Media Mavericks: The Investment Potential of QYOU Media; India's Exponentially Growing Content Powerhouse

149

Sharps Technology, Inc. (NASDAQ: STSS): Sustainable Solutions, Profitable Investments: Inside the No Waste Syringe Revolution

150

Graphex Group Ltd. (NYSE American: GRFX) Unearthed: Unveiling the Hidden Powerhouse – The Podcast Exploring Graphex Groups Dominance in the Graphite Market

151

Lantern Pharma (NASDAQ: LTRN): Investing in Tomorrow's Cures: Unveiling the Power of AI Drug Development Platforms